Peringkat dalam Saham
#38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Harga Saham
$0.00953895
Terakhir disinkronkan: 2024-05-22
Kapitalisasi Pasar
$1.28M
Perubahan (1 tahun)
0.00%
Perdagangan Evgen Pharma plc (EVG)
Harga EVG dengan kapitalisasi pasar B
Kapitalisasi pasar dari Evgen Pharma plc(EVG)
Kapitalisasi Pasar: $1.28M
Per August 2026, Evgen Pharma plc memiliki kapitalisasi pasar sebesar $1.28M. Ini menjadikan Evgen Pharma plc sebagai perusahaan 38016th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Evgen Pharma plc dari 2015 hingga 2026
EVG dibandingkan dengan 5 teratas stocks paling populer
| Harga EVG |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+424,564,517.03%
|
|
|
|
|
$4.490T
|
+349,660,564.35%
|
|
|
|
|
$4.162T
|
+324,147,665.18%
|
|
|
|
|
$3.676T
|
+286,295,348.85%
|
|
|
|
|
$2.833T
|
+220,623,311.32%
|
